Profile

Cover photo
See It Market
114 followers|31,217 views
AboutPostsPhotosVideos

Stream

See It Market

Shared publicly  - 
 
James Bartelloni provides an update on Alphabet stock $GOOGL after Monday's earnings pushed the stock price up to his wave 5 price target.

James Bartelloni has a simple reason why Alphabet stock (GOOGL) reversed lower after reporting solid earnings: the GOOGL wave 5 price target was hit.
1
Add a comment...

See It Market

Shared publicly  - 
 
Gold prices have rallied in the early going of 2016 as investors rotate money out of equities. Shane Obata shares some reasons why this trend may continue throughout the rest of the year. 
The gold bulls have been wrong for a handful of years; however, that may be about to change writes Shane Obata.
1
Add a comment...

See It Market

Shared publicly  - 
 
Michael Lebowitz sees the Bank of Japan's move to negative interest rates as a major warning for the financial markets.
Last Friday the Bank of Japan surprised the markets and enacted a negative interest rate policy. Michael Lebowitz thinks this is a warning for investors.
1
Add a comment...

See It Market

Shared publicly  - 
 
Argentina's corn market plays a big role in the supply and demand of global corn trade. What is the latest series of data points telling us. Marcus Ludtke examines.
March corn futures enjoyed a rally on Friday but appear to have run into some significant headwinds once again with corn prices over $3.70 per bushel.
1
Add a comment...

See It Market

Shared publicly  - 
 
Steve Deppe looks at the historic stock market decline in January and shares some quantitative stats on what it might mean for the rest of 2016.

The S&P 500 declined -5.07% in January, the 8th worst performing stock market returns for the month since 1950. What could this mean for the rest of 2016?
1
Add a comment...

See It Market

Shared publicly  - 
 
Facebook earnings report sent the stock soaring. Ophir Gottlieb shares some additional reasons why Facebook's stock is soaring.
Last week, Facebook reported a big earnings beat for 4th quarter, sending its stock price to new highs. But there's more to the story writes Ophir Gottlieb.
1
Add a comment...
Have them in circles
114 people
S&P Euro350 news's profile photo
Financial Enhancement Group's profile photo
Robert Kal's profile photo
Ed S's profile photo
Maria Rinehart's profile photo
Gina Spencer's profile photo
Sheldon McIntyre's profile photo
Ivan Milevskii's profile photo
Ryan Detrick's profile photo

See It Market

Shared publicly  - 
 
The market is trying to keep the bounce alive but uncertainty is creating volatile choppy trading for investors.
The stock market has a lot to prove here still. Follow the price action, resistance, support and pivots with Fibonacci levels, says Venky Srinivasan.
1
Add a comment...

See It Market

Shared publicly  - 
 
Defensive stocks are leading the market off the lows. Will the rally turn into something bigger?

The stock market rally off the January lows has been volatile and unnerving. But downside momentum has been broken which may fuel another rally attempt.
1
Add a comment...

See It Market

Shared publicly  - 
 
Stagnant wage growth and beaten down commodity prices may wind up spurring the next phase of economic growth, writes Maria Rinehart.

If history is our guide, historically low labor and commodities costs may mean we are at the front end of a new growth cycle, states Maria Rinehart.
1
Add a comment...

See It Market

Shared publicly  - 
 
Joe Kunkle - OptionsHawk- analyzes options trading order flow and shows why traders are bracing for more market volatility.
Options trading order flow indicates a potential for increased volatility into March, writes Joe Kunkle. He points to options "strangles" for select stocks.
1
Add a comment...

See It Market

Shared publicly  - 
 
Drasko Kovrlija shares some insights into January's stock market decline why another correction is occurring.
1
Add a comment...

See It Market

Shared publicly  - 
 
The biotech sector is oversold and nearing a short-term bottom. Tom Pizzuti shows why Biotech stocks may be nearing a countertrend rally.
Biotech stocks have declined sharply over the past several weeks. But the Biotech Sector ETF (XBI) may be nearing a countertrend rally, writes Tom Pizzuti.
1
Add a comment...
People
Have them in circles
114 people
S&P Euro350 news's profile photo
Financial Enhancement Group's profile photo
Robert Kal's profile photo
Ed S's profile photo
Maria Rinehart's profile photo
Gina Spencer's profile photo
Sheldon McIntyre's profile photo
Ivan Milevskii's profile photo
Ryan Detrick's profile photo
Story
Tagline
where investing & economics collide
Introduction
Investing, Technical Analysis, and Stock Market News & Commentary. Research for active investors. Founded by Andrew Nyquist.